share_log

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

達維達公司安排2024年第三季度投資者電話會議
德維特 ·  10/09 12:00

DENVER, Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

2024年10月9日,丹佛/PRNewswire/ -- 德維特股份有限公司(紐交所:DVA)今日宣佈,將於2024年10月29日星期二美國東部時間下午5:00舉行季度電話會議,討論第三季度業績。該公司計劃在同一天收盤後發佈其業績。

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

這次電話會議也將通過DaVita投資者關係網頁進行網絡直播,您可以按以下方式參加此次電話會議:

Tuesday, October 29, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042

2024年10月29日星期二
電話會議將於美國東部時間下午5點開始。
可通過此鏈接訪問網絡直播。
撥入電話號碼:877-918-6630。
國際撥入電話號碼:517-308-9042。

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.

在致電時,請向運營商提供密碼「Earnings」,並提供您的姓名和公司名稱。無法聽取電話會議的投資者將能夠通過我們的網站investors.davita.com訪問重播。不提供電話重播。

About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

關於德維特公司
德維特(NYSE:DVA)是一家以改善全球患者生活質量爲目標的醫療保健服務提供商。作爲一家綜合腎臟護理提供商,德維特在臨床質量和創新方面已經領先20多年。德維特在腎臟健康旅程的每個階段和環境中護理患者——從減緩腎臟疾病的進展到幫助支持移植,從急性醫院護理到家庭透析。截至2024年6月30日,德維特在3,124個門診透析中心爲約265,100名患者提供服務,其中2,672箇中心位於美國,452箇中心位於全球13個其他國家。德維特已經減少住院次數,改善死亡率,並共同努力推動腎臟護理行業採用公平和高質量的醫療標準,以惠及全球所有患者。欲了解更多信息,請訪問DaVita.com/About。

Contact Information
Investors:
IR@davita.com

聯繫信息
投資者:
IR@davita.com

big

SOURCE DaVita

SOURCE 德維特

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論